Cause of spontaneous hives pinpointed by clinical study

July 3, 2017
Cause of spontaneous hives pinpointed by clinical study
Clinician-scientist Dr Priscilla Auyeung has discovered why some people spontaneously develop itchy hives with no apparent trigger, a condition called chronic spontaneous urticaria. Credit: Walter and Eliza Hall Institute of Medical Research

Melbourne researchers have solved a longstanding mystery about why some people develop recurring, itchy hives without an apparent allergic trigger, a condition known as chronic spontaneous urticaria (CSU).

Hives or 'urticaria' are itchy raised welts on the skin caused by an inflammatory reaction. A team of researchers at the Walter and Eliza Hall Institute and the Royal Melbourne Hospital have discovered how CSU develops, and are now working towards better treatments – or even a cure – for this condition.

Dr Priscilla Auyeung, a clinical immunologist at the Royal Melbourne Hospital and clinician-scientist at the Walter and Eliza Hall Institute, said people with CSU found it very frustrating that there was no obvious trigger for their hives.

"One in five Australians will experience hives at some stage of their lives. Sometimes it's an allergy, when a reaction is linked to an external trigger or allergen – such as contact with a particular type of animal or plant, or eating a certain food," Dr Auyeung said.

"However, CSU is different. People with CSU develop recurring hives for periods of at least six weeks – and often for many years – but with no apparent trigger. Our patients often think that they're allergic to their washing powder, soap or shampoo, and sometimes even wonder if it is all in their mind."

Cause of spontaneous hives pinpointed by clinical study
Dr Auyeung is now leading clinical studies at the Royal Melbourne Hospital that could potentially lead to a new therapy for chronic spontaneous urticaria.  Credit: Walter and Eliza Hall Institute of Medical Research

In research published in the Journal of Allergy and Clinical Immunology, Dr Auyeung and colleagues Professor Len Harrison, Dr Diana Mittag and Professor Phil Hodgkin used samples from CSU patients attending the Royal Melbourne Hospital to investigate whether the hives were caused by immune T .

"We found that in the majority of people with CSU, T cells reacted to a specific protein found on other immune cells, called mast cells, in the skin. This aberrant 'autoimmune' T cell response drives the inflammation that causes itchy hives in CSU," Dr Auyeung said.

Dr Auyeung has recently begun new studies to investigate whether the autoimmune T cells that trigger CSU could be switched off by new, targeted treatments.

"We're using blood samples from CSU patients at the Royal Melbourne Hospital to home in on the precise molecules that trigger the immune response," she said.

"In recent years we've seen new 'immune modulatory' therapies developed that switch off the damaging immune response underlying other immune disorders, such as allergies and type 1 diabetes. We're hoping to use the same techniques to develop a new therapy that could potentially bring relief to people with CSU."

Explore further: Which comes first: Self-reported penicillin allergy or chronic hives?

More information: Priscilla Auyeung et al. Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit, Journal of Allergy and Clinical Immunology (2016). DOI: 10.1016/j.jaci.2016.04.036

Related Stories

Which comes first: Self-reported penicillin allergy or chronic hives?

February 3, 2016
People who have self-reported penicillin allergy may have a three times greater chance of suffering from chronic hives. And people who have chronic hives tend to self-report penicillin allergy at a three times greater rate ...

Summer's heat may enflame hives

May 30, 2012
(HealthDay) -- Nearly one in four people develops hives at some time or another, and they can be triggered by hot summer weather.

Asthma drug helps patients with skin disorder

April 7, 2017
Patients who develop itchy wheals in response to cold or friction benefit from treatment with omalizumab, a drug normally used to treat asthma. Two separate clinical studies, conducted by researchers from Charité - Universitätsmedizin ...

Gene therapy could 'turn off' severe allergies

June 2, 2017
A single treatment giving life-long protection from severe allergies such as asthma could be made possible by immunology research at The University of Queensland.

Got hives? Hold the steroids

May 3, 2017
Despite standard use for the itching associated with urticaria (commonly known as hives), prednisone (a steroid) offered no additional relief to emergency patients suffering from hives than a placebo did, according to a randomized, ...

New clue in celiac disease puzzle: Cause of oat toxicity explained

November 18, 2014
Melbourne researchers have identified why some people with coeliac disease show an immune response after eating oats.

Recommended for you

Immune cells turn back time to achieve memory

December 13, 2017
Memory T cells earn their name by embodying the memory of the immune system - they help the body remember what infections or vaccines someone has been exposed to. But to become memory T cells, the cells go backwards in time, ...

Steroid study sheds light on long term side effects of medicines

December 13, 2017
Fresh insights into key hormones found in commonly prescribed medicines have been discovered, providing further understanding of the medicines' side effects.

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Researchers bring new insight into Chediak-Higashi syndrome, a devastating genetic disease

December 12, 2017
A team of researchers from the National Institutes of Health and University of Manchester have uncovered new insights into a rare genetic disease, with less than 500 cases of the disease on record, which devastates the lives ...

Drug increases speed, safety of treatment for multiple food allergies

December 11, 2017
In a randomized, controlled phase-2 clinical trial, an asthma medication increased the speed and safety of a protocol used to treat children for several food allergies at once, according to a study by researchers at the Stanford ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.